D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Amazon
AMZN
|
+$490M |
| 2 |
Microsoft
MSFT
|
+$461M |
| 3 |
Estee Lauder
EL
|
+$422M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$239M |
| 5 |
Nike
NKE
|
+$234M |
Top Sells
| 1 |
Walmart
WMT
|
+$585M |
| 2 |
Tesla
TSLA
|
+$470M |
| 3 |
NVIDIA
NVDA
|
+$431M |
| 4 |
Eli Lilly
LLY
|
+$360M |
| 5 |
T-Mobile US
TMUS
|
+$299M |
Sector Composition
| 1 | Technology | 26.44% |
| 2 | Consumer Discretionary | 14.71% |
| 3 | Healthcare | 12.37% |
| 4 | Financials | 8.93% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2426
ALX Oncology
ALXO
$56.2M
| $219K | ﹤0.01% |
45,682
-2,525
| -5% | -$12.1K |
|
|
AXNX
2427
DELISTED
Axonics, Inc. Common Stock
AXNX
| $218K | ﹤0.01% |
3,893
-36,598
| -90% | -$2.05M |
|
2428
Hanesbrands
HBI
$2.22B
| $218K | ﹤0.01% |
55,100
-63,350
| -53% | -$251K |
|
2429
NVE Corp
NVEC
$319M
| $217K | ﹤0.01% |
2,640
-3,327
| -56% | -$273K |
|
|
OGI
2430
Organigram Holdings
OGI
$237M
| $215K | ﹤0.01% |
162,425
-104,475
| -39% | -$139K |
|
2431
First Financial Bancorp
FFBC
$2.42B
| $215K | ﹤0.01% |
+10,984
| New | +$215K |
|
2432
Banco de Chile
BCH
$15B
| $215K | ﹤0.01% |
10,647
-20,141
| -65% | -$407K |
|
2433
Anavex Life Sciences
AVXL
$754M
| $213K | ﹤0.01% |
32,541
-12,563
| -28% | -$82.3K |
|
2434
Camden National
CAC
$674M
| $212K | ﹤0.01% |
+7,512
| New | +$212K |
|
2435
ADT
ADT
$7.06B
| $212K | ﹤0.01% |
35,317
-77,287
| -69% | -$464K |
|
2436
Preferred Bank
PFBC
$1.14B
| $211K | ﹤0.01% |
+3,397
| New | +$211K |
|
2437
CSX Corp
CSX
$61.1B
| $210K | ﹤0.01% |
6,830
-62,780
| -90% | -$1.93M |
|
2438
Sensus Healthcare
SRTS
$50.8M
| $210K | ﹤0.01% |
75,794
-16,982
| -18% | -$47K |
|
2439
Atea Pharmaceuticals
AVIR
$231M
| $210K | ﹤0.01% |
69,949
-13,473
| -16% | -$40.4K |
|
2440
First Merchants
FRME
$2.3B
| $209K | ﹤0.01% |
+7,507
| New | +$209K |
|
2441
Innodata
INOD
$2.13B
| $208K | ﹤0.01% |
+24,411
| New | +$208K |
|
|
DSKE
2442
DELISTED
Daseke, Inc. Common Stock
DSKE
| $208K | ﹤0.01% |
40,500
-17,892
| -31% | -$91.8K |
|
2443
Workhorse Group
WKHS
$17.1M
| $207K | ﹤0.01% |
+2,000
| New | +$207K |
|
2444
Evercore
EVR
$13.4B
| $207K | ﹤0.01% |
+1,500
| New | +$207K |
|
|
VCXB
2445
DELISTED
10X Capital Venture Acquisition Corp. III
VCXB
| $206K | ﹤0.01% |
19,251
| – | – |
|
|
ALX
2446
Alexander's
ALX
$1.19B
| $205K | ﹤0.01% |
+1,126
| New | +$205K |
|
2447
Herbalife
HLF
$960M
| $205K | ﹤0.01% |
14,663
-76,317
| -84% | -$1.07M |
|
2448
Saic
SAIC
$4.73B
| $205K | ﹤0.01% |
1,942
-7,151
| -79% | -$755K |
|
2449
EchoStar
SATS
$20.7B
| $204K | ﹤0.01% |
12,202
-125,075
| -91% | -$2.1M |
|
2450
STAG Industrial
STAG
$6.61B
| $204K | ﹤0.01% |
5,910
-24,632
| -81% | -$850K |
|